Liquidity rebuilt
Net financing supported the cash recovery while operating activities consumed funds.
European Metals Holdings’ financial review follows its equity-accounted Cinovec exposure through funding, study work and a fiscal-year change. The June-year series and the six-month transition are separated from calendar 2025, when cash fell and Geomet funding obligations remained significant.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
Not the June 2025 balance.
Calendar-year group result.
Included in the net loss.
Equity-accounted associate.
EMH has a 49% interest in Geomet, with significant influence rather than control or joint control. Cinovec project forecasts therefore are not consolidated production revenue, and the project’s full asset base is not EMH’s reported asset total.
The prior-period change to December year end creates an extra six-month reporting period. This review uses June 2024 annual comparatives for the five annual columns and shows July-December 2024 separately.
Net financing supported the cash recovery while operating activities consumed funds.
Net financing increased cash at June year end.
Payments to the associate account for most investing cash outflow.
The June year includes further associate investment; a separate six-month transition then moves the year end to December.
Geomet funding was supported by placement and Dukla-loan refinancing; the loan derecognition generated a disposal loss.
The cash balance is small relative to reported assets. Maintaining the Geomet interest depends on meeting proportional cash calls; failure could lead to dilution under the shareholder agreement.
A$ million
AI-generated presentation · values from Balance dates - June 2021-2024 and December 2025; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Balance dates - June 2021-2024 and December 2025; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash and equivalents | 7.881 | 19.056 | 8.893 | 4.727 | 0.397 |
| Total assets | 25.915 | 36.973 | 37.268 | 37.318 | 35.147 |
| Total equity | 25.278 | 35.800 | 36.307 | 36.483 | 32.211 |
FY2021-FY2024 columns are 30 June; FY2025 is 31 December. The intervening six-month transition is shown separately below. Geomet is equity-accounted, not consolidated line by line.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The FY2025 loan sale generated cash but also a loss; associate investment payments exceeded disposal proceeds. Neither a study valuation nor proposed project capacity is cash available to EMH.
A$ million
AI-generated presentation · values from Twelve-month losses and operating cash; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Twelve-month investing and financing; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Loss after tax | (3.962) | (6.803) | (5.928) | (3.356) | (8.211) |
| Net operating cash flow | (2.292) | (2.577) | (1.840) | (3.422) | (1.146) |
FY2021-FY2024 end June; FY2025 is calendar 2025. Do not read these as five uninterrupted June fiscal years.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Net investing cash flow | 0.000 | 0.000 | (8.424) | (11.395) | (5.416) |
| Net financing cash flow | 10.111 | 13.757 | (0.049) | 10.943 | 3.515 |
FY2021-FY2022 investing dashes denote no net investing cash flow, consistent with the cash reconciliation.
FY2025 investing combines Geomet investment payments and proceeds from disposal of the Dukla loan; it is not gross project spending.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | 6m to Dec 2024 |
|---|---|
| Loss after tax | (1.251) |
| Operating cash flow | (1.274) |
| Financing cash flow | (0.044) |
| Closing cash | 3.524 |
This additional transition period is not annualised or hidden inside FY2024. Closing cash includes A$0.115m exchange-rate effect.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The issuer reports no ready access to credit facilities and relies primarily on equity funding. Material going-concern uncertainty relates specifically to sustaining its current Geomet ownership strategy.
The 2025 statutory loss includes equity-accounted associate losses and the Dukla loan-disposal loss. The December DFS’s forecast production and returns are not operating actuals or a valuation of listed EMH shares.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.